Browse drug registration pathways, regulators, CTD dossier expectations, review procedures, holder duties, and post-approval obligations by country.
Public pages show drug registration overviews; during the limited-time free period, sign in or register to view complete pathways.
Drug registration routes in the same region often share CTD structure, local holder, GMP/CPP, label-language, and post-approval patterns. Start with the regional pattern, then open the country page for differences.
Typical flow: local holder or agent, CTD/eCTD, CPP/GMP, label-language work, and pharmacovigilance setup. LATAM markets often require Spanish/Portuguese localization and may focus on BE or clinical bridging.
Typical flow: local MAH/agent, CTD or ASEAN CTD, GMP/CPP, samples/testing, and label-language checks. ASEAN markets share dossier logic; China, Japan, and Korea have heavier local clinical and administrative requirements.
Typical flow: EU CTD, centralized/MRP/DCP/national route, QP/PV system, SmPC/PIL, and local languages. UK, Switzerland, and other non-EU markets require separate holders and filing routes.
Typical flow: local agent or holder, CTD, CPP/GMP, legalization, Arabic labeling, and local pharmacovigilance contact. GCC markets can reference one another but still keep local submission and fee steps.
7 countries
Typical flow: local holder or agent, CTD/eCTD, CPP/GMP, label-language work, and pharmacovigilance setup. LATAM markets often require Spanish/Portuguese localization and may focus on BE or clinical bridging.
Market Overview Market profile: Argentina is shaped by public procurement, private insurance, price controls, and FX constraints. Local pharmaceutical capability is strong, while i...
Updated: 2026-05-04
Market Overview Market profile: Brazil is Latin America's largest pharmaceutical market. SUS procurement, private channels, local manufacturing preference, and Portuguese complianc...
Updated: 2026-05-04
Market Overview Market profile: Canada has high regulatory quality expectations. English/French labeling, NDS/ANDS pathways, patent linkage, and provincial reimbursement are critic...
Updated: 2026-05-04
Market Overview Market profile: Chile has a relatively transparent regulatory environment and high import dependence. ISP registration is required before import, distribution, and...
Updated: 2026-05-04
Market Overview Market profile: INVIMA regulates medicines and biologics. Public insurance, EPS entities, and hospital procurement shape commercial access. Regulatory maturity: Med...
Updated: 2026-05-04
Market Overview Market profile: Mexico is a core Latin American pharmaceutical market. COFEPRIS registration, public procurement, private pharmacy channels, and Spanish labeling ar...
Updated: 2026-05-04
Market Overview Market profile: The United States is the largest global prescription drug and biologics market. Commercial upside is high, but evidence expectations, clinical devel...
Updated: 2026-05-04
